Physician

David Scott Sharp, M.D.

According to 2025 Medicare claims, David Sharp, M.D. (NPI: 1275720344) practices urology in the Fairbanks-College, AK market, with the plurality of this provider's patient population coming from Fairbanks North Star, AK. This provider's primary affiliated billing organization is FAIRBANKS UROLOGY (NPI: 1043727878; TIN: 823785749) and primary practice location at 99701-4680.

Sharp's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 722 traditional Medicare patients, billed 5,277 HCPCS/CPT codes, and received $493,022 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 586 prescription claims across 221 beneficiaries totaling $52,796 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 120 claims. Open Payments data shows 22 records totaling $1,067. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $113,845 to $493,022. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $197,986 and ending at $52,796. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	327	796	$113,845
2016	383	896	$102,237
2017	392	992	$111,716
2018	399	943	$103,721
2019	405	904	$105,490
2020	295	737	$84,578
2021	376	3,512	$354,197
2022	480	6,175	$369,916
2023	924	12,302	$492,849
2024	722	5,277	$493,022

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	65	186	$197,986
2016	80	240	$106,773
2017	82	225	$63,093
2018	57	185	$126,482
2019	63	196	$296,631
2020	37	89	$67,645
2021	131	329	$18,839
2022	169	563	$38,400
2023	233	653	$70,612
2024	221	586	$52,796

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	35	$3,786
2016	N/R	14	$654
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	22	$2,059
2023	N/R	44	$5,080
2024	N/R	120	$40,890

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	210	254	$164
76872	Ultrasound scan of pelvic region through rectum	158	177	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	459	699	$113
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	207	240	$80
36415	Insertion of needle into vein for collection of blood sample	272	348	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	32	1,431	$21,985
Gemtesa	Vibegron	63	1,439	$21,665
Tamsulosin Hcl	Tamsulosin Hcl	172	14,113	$2,790
Finasteride	Finasteride	54	4,860	$1,005
Solifenacin Succinate	Solifenacin Succinate	17	1,220	$834

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	32	$32,224
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	65	$8,433
A4332	Lubricant, individual sterile packet, each	N	N/R	23	$233

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$1,067	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Scott Sharp, M.D.?

Tedicare shows public-source Medicare data for David Scott Sharp, M.D. (NPI 1275720344), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Scott Sharp, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Scott Sharp, M.D.?

David Scott Sharp, M.D. is linked to FAIRBANKS UROLOGY (billing NPI 1043727878) in the available physician profile data.

Does David Scott Sharp, M.D. have Open Payments data?

David Scott Sharp, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.